Latest Research on Molecular Imaging for Cancer Diagnosis and Prognosis

Dear Colleagues,

Molecular imaging (MI), defined as the ability to characterize and gauge molecular processes at a cellular and molecular level, has been gaining a central role in many oncological pathways of diagnosis and care. Due to its strong multidisciplinary nature, encompassing different branches of the “imaging sciences” (nuclear medicine, radiology, optical imaging, etc.), MI is strongly correlated with the concept of personalized medicine, a new approach based on the principle that each individual has unique biological characteristics. In this perspective, MI offers the opportunity to identify specific tumor-associated biomarkers suitable for patients’ stratification before molecularly targeted therapies and for the assessment of response. For example, the identification of a prostate-specific membrane antigen (PSMA) by PET/CT represents an essential step in patients with advanced prostate cancer before the enrollment for PSMA-targeted radionuclide therapies with beta- or alpha-emitters. In this perspective, the emerging discipline of “radiomics”, aimed at extracting data from medical images undetectable to the naked eye but with potentially relevant clinical usefulness, represents a still little-explored field of research.

In this Special Issue, we solicit original contributions (reviews, original articles, etc.) focusing on the role of molecular imaging (PET, MRI, SPECT, optical imaging, radiomics) in oncology.

Dr. Luca Filippi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.